InvestorsHub Logo
Followers 827
Posts 119469
Boards Moderated 15
Alias Born 09/05/2002

Re: DewDiligence post# 739

Wednesday, 04/20/2022 10:49:15 AM

Wednesday, April 20, 2022 10:49:15 AM

Post# of 803
ABT sold $3.3B of COVID diagnostics in 1Q22:

https://abbott.mediaroom.com/2022-04-20-Abbott-Reports-First-Quarter-2022-Results

Full-year 2022 non-GAAP EPS guidance remains unchanged at $4.70+. This guidance includes only $1.2B of cumulative COVID-diagnostics sales for 2Q22/3Q22/4Q22, which seems like a conservative forecast.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABT News